TF, which is secreted into sEVs derived from hypoxic glioma cells, triggers angiogenesis in human umbilical vein endothelial cells by activating protease activate receptor 2 (PAR2), triggering subsequent Erk phosphorylation [44]. The gene discussed is F2RL1; the disease is glioma.